Latest / Hart2Heart with Dr. Mike Hart
#240 Dr. Spencer Nadolsky on Repatha, ApoB Targets, and What Actually Matters in Lipidology
Dr. Mike Hart sits down with lipidologist Dr. Spencer Nadolsky for a practical discussion on cardiovascular prevention, cholesterol management, and metabolic health. They break down how to interpret ApoB, LDL, HDL, triglycerides, and Lp(a), when cholesterol-lowering medications may make sense, and why long-term exposure matters when thinking about heart disease risk. The conversation also explores statins, PCSK9 inhibitors, plaque progression, supplements, insulin resistance, and the evolving role of GLP-1 medications in obesity treatment and long-term cardiometabolic health.
Dr. Spencer…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.